BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

SQURPHARMA

All Eps Dividend Board Agm Q1 Q2 Q3

SQURPHARMA 10-Oct-2022

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 20, 2022 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2022.

ঢাকা স্টক এক্সচেঞ্জ (লিস্টিং) রেগুলেশন, 2015-এর রেগুলেশন 19(1) অনুযায়ী, কোম্পানি জানিয়েছে যে 20 অক্টোবর, 2022 বিকাল 3:00 টায় পরিচালনা পর্ষদের একটি সভা অন্যান্যদের মধ্যে বিবেচনা করার জন্য অনুষ্ঠিত হবে, 30 জুন, 2022 সমাপ্ত বছরের জন্য কোম্পানির নিরীক্ষিত আর্থিক বিবৃতি।

SQURPHARMA 21-Apr-2022

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 27, 2022 at 2:15 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2022.

ঢাকা স্টক এক্সচেঞ্জ (লিস্টিং) রেগুলেশন, 2015 এর রেগুলেশন 16(1) অনুসারে, কোম্পানি জানিয়েছে যে 27 এপ্রিল, 2022 তারিখে দুপুর 2:15 টায় পরিচালনা পর্ষদের একটি সভা অন্যান্যদের মধ্যে বিবেচনা করার জন্য অনুষ্ঠিত হবে, 31 মার্চ, 2022 তারিখে শেষ হওয়া তৃতীয় ত্রৈমাসিকের (Q3) সময়ের জন্য কোম্পানির অনিরীক্ষিত আর্থিক বিবৃতি।

SQURPHARMA 25-Jan-2022

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 31, 2022 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2021.

ঢাকা স্টক এক্সচেঞ্জ (লিস্টিং) রেগুলেশন, 2015-এর রেগুলেশন 16(1) অনুসারে, কোম্পানিটি জানিয়েছে যে 31 জানুয়ারী, 2022 তারিখে বিকাল 3:00 টায় পরিচালনা পর্ষদের একটি সভা অন্যান্যদের মধ্যে বিবেচনা করার জন্য অনুষ্ঠিত হবে, ৩১ ডিসেম্বর, ২০২১ তারিখে শেষ হওয়া দ্বিতীয় ত্রৈমাসিকের (Q2) সময়ের জন্য কোম্পানির অ-নিরীক্ষিত আর্থিক বিবৃতি।

SQURPHARMA 08-Nov-2021

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 14, 2021 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2021.

SQURPHARMA 24-Oct-2021

The Board of Directors has recommended 60% cash dividend for the year ended on June 30, 2021. The Board has also approved Tk. 300.00 crore for BMRE, Capital Machineries and Lands for future expansion. Date of AGM: 15.12.2021, Time: 10:00 AM, Venue: Digital Platform. Record Date: 22.11.2021. (cont.1)

SQURPHARMA 10-Oct-2021

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 21, 2021 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2021.

SQURPHARMA 02-May-2021

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on May 06, 2021 at 1:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2021.

SQURPHARMA 24-Jan-2021

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 28, 2021 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2020.

SQURPHARMA 18-Nov-2020

The auditor of the Square Pharmaceuticals Ltd has given the "Emphasis of Matter " paragraph in the Auditor's Report for the year ended on 30 June 2020. Emphasis of Matter: We draw attention to the note no. 8 to the separate financial statements, which describes the loans given to subsidiaries and associates as well as companies with common directors. The company obtained approval for such loans from the Board of Directors. Our opinion is not modified in this regard. (cont.)

SQURPHARMA 09-Nov-2020

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 12, 2020 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2020.

Previous Next page